Respir Care
an affiliate of the Nicaragua-based Pellas Group and manufacturer of juice products in an action by Del Monte International, GmbH seeking to prevent Ticofrut from purchasing pineapples from its primary supplier based on an arbitral award that Del Monte obtained against that supplier Representation of a leading international financial institution in connection with the defense of securities and related fraud claims arising from a 250 million collateralized debt obligation offering backed by a portfolio of asset-backed securities Representation of the Central Bank of Paraguay in an action to successfully recover funds misappropriated from two Paraguayan banks in liquidation Representation of Caja Paraguaya de Jubilaciones y Pensiones del Personal de la Itaip Binacional the retirement fund manager for Paraguayan employees of the joint Brazilian/Paraguayan Itaip Binacional hydroelectric dam project - in the prosecution of its worldwide strategy to recover funds invested in a fraudulent scheme and other failed offerings Representation of Banco Alemn del Paraguay in actions to successfully recover funds improperly transferred as part of a fraudulent scheme Representation of the Agencia de Garanta de Depsitos of the Republic of Ecuador (the Ecuadorean Federal Deposit Insurance Corp.), acting on behalf of Banco Popular del Ecuador SA, an Ecuadorean bank, in securing the dismissal of a $180 million RICO action filed by the Republic of Colombia based upon the alleged misappropriation of taxes and customs duties by a Colombian affiliate of the Ecuadorean bank Representation of Barclays Bank PLC, Miami Agency, in obtaining the dismissal of a breach of contract action arising out of a $75 million syndicated loan transaction designed to restructure "trade-related debt" of a number of Ecuadorean banks Representation of the outside directors of Corporate Resources Services, Inc
The trademark license agreement covers fifteen years, to January 29, 2038, with performance-review cycles and associated commitments, based on volume, to be confirmed for each three-year period, to allow flexibility for evolving market conditions
Secondhand smoke can also be dangerous
The first nonnicotine medication FDA approved for smoking cessation was sustained-release bupropion (Zyban, GlaxoSmithKline, Philadelphia)
